219 related articles for article (PubMed ID: 2050241)
21. Quantification of low density lipoprotein binding and cholesterol accumulation by single human fibroblasts using fluorescence microscopy.
Kruth HS; Vaughan M
J Lipid Res; 1980 Jan; 21(1):123-30. PubMed ID: 6986448
[TBL] [Abstract][Full Text] [Related]
22. Clinical studies in a kindred with a kinetic LDL receptor mutation causing familial hypercholesterolemia.
Bilheimer DW; East C; Grundy SM; Nora JJ
Am J Med Genet; 1985 Nov; 22(3):593-8. PubMed ID: 4061492
[TBL] [Abstract][Full Text] [Related]
23. [Homozygous familial hypercholesterolemia: development and a case illustration].
Choukri M; Laaroussi N; Taheri H; Chabraoui L
Ann Biol Clin (Paris); 2013; 71(1):99-103. PubMed ID: 23396432
[TBL] [Abstract][Full Text] [Related]
24. Role of LDL apheresis in a case of homozygous familial hypercholesterolemia.
Naveen T; Biswas A; Wig N; Soneja M; Jorwal P; Durga CS; Singla P; Chaudhary C; Baitha U
Drug Discov Ther; 2019; 13(1):59-61. PubMed ID: 30880324
[TBL] [Abstract][Full Text] [Related]
25. Biochemical genetics of LDL receptor mutations in familial hypercholesterolemia.
Goldstein JL; Kottke BA; Brown MS
Prog Clin Biol Res; 1982; 103 Pt B():161-76. PubMed ID: 6298809
[No Abstract] [Full Text] [Related]
26. Accumulation of "small dense" low density lipoproteins (LDL) in a homozygous patients with familial defective apolipoprotein B-100 results from heterogenous interaction of LDL subfractions with the LDL receptor.
März W; Baumstark MW; Scharnagl H; Ruzicka V; Buxbaum S; Herwig J; Pohl T; Russ A; Schaaf L; Berg A
J Clin Invest; 1993 Dec; 92(6):2922-33. PubMed ID: 8254047
[TBL] [Abstract][Full Text] [Related]
27. Prospects for gene therapy of familial hypercholesterolemia.
Wilson JM; Chowdhury JR
Mol Biol Med; 1990 Jun; 7(3):223-32. PubMed ID: 2215209
[TBL] [Abstract][Full Text] [Related]
28. Multiple flexor tendon xanthomas and contractures in the hands of a child with familial hypercholesterolemia.
Gunther SF; Gunther AG; Hoeg JM; Kruth HS
J Hand Surg Am; 1986 Jul; 11(4):588-93. PubMed ID: 3722777
[TBL] [Abstract][Full Text] [Related]
29. Free fatty acids activate a high-affinity saturable pathway for degradation of low-density lipoproteins in fibroblasts from a subject homozygous for familial hypercholesterolemia.
Bihain BE; Yen FT
Biochemistry; 1992 May; 31(19):4628-36. PubMed ID: 1581314
[TBL] [Abstract][Full Text] [Related]
30. Liver transplantation to provide low-density-lipoprotein receptors and lower plasma cholesterol in a child with homozygous familial hypercholesterolemia.
Bilheimer DW; Goldstein JL; Grundy SM; Starzl TE; Brown MS
N Engl J Med; 1984 Dec; 311(26):1658-64. PubMed ID: 6390206
[TBL] [Abstract][Full Text] [Related]
31. Familial hypercholesterolemia: mechanism of inheritance.
de Oya M; Nuno J; Azpeitia AG; Villasante JG
Diabete Metab; 1980 Sep; 6(3):181-8. PubMed ID: 7439491
[TBL] [Abstract][Full Text] [Related]
32. Familial hypercholesterolemia with extensive coronary artery disease and tuberous and tendinous xanthomas: A case report and mutation analysis.
Agirbasli D; Hyatt T; Agirbasli M
J Clin Lipidol; 2018; 12(4):863-867. PubMed ID: 29784571
[TBL] [Abstract][Full Text] [Related]
33. The LDL receptor defect in familial hypercholesterolemia. Implications for pathogenesis and therapy.
Goldstein JL; Brown MS
Med Clin North Am; 1982 Mar; 66(2):335-62. PubMed ID: 6279983
[TBL] [Abstract][Full Text] [Related]
34. Hypocholesterolaemic factor from gallbladder cancer cells.
Ueyama Y; Matsuzawa Y; Yamashita S; Funahashi T; Sakai N; Nakamura T; Kubo M; Tarui S
Lancet; 1990 Sep; 336(8717):707-9. PubMed ID: 1975892
[TBL] [Abstract][Full Text] [Related]
35. A xanthomatosis-susceptibility gene may exist in a Syrian family with familial hypercholesterolemia.
Vergopoulos A; Bajari T; Jouma M; Knoblauch H; Aydin A; Bähring S; Mueller-Myhsok B; Dresel A; Joubran R; Luft FC; Schuster H
Eur J Hum Genet; 1997; 5(5):315-23. PubMed ID: 9412789
[TBL] [Abstract][Full Text] [Related]
36. Histochemical characterization of low density lipoprotein receptors in internalization-defective familial hypercholesterolemia.
Takaichi S; Tajima S; Miyake Y; Yamamoto A
Arteriosclerosis; 1985; 5(3):238-43. PubMed ID: 3922339
[TBL] [Abstract][Full Text] [Related]
37. Phagocytic degradation of chylomicron remnants by fibroblasts from subjects with homozygous familial hypercholesterolaemia.
YU KC; Smith D; Yamamoto A; Kawaguchi A; Harada-Shiba M; Yamamura T; Mamo JC
Clin Sci (Lond); 1997 Feb; 92(2):197-203. PubMed ID: 9059322
[TBL] [Abstract][Full Text] [Related]
38. Familial hypercholesterolemia: a genetic receptor disease.
Goldstein JL; Brown MS
Hosp Pract (Off Ed); 1985 Nov; 20(11):35-41, 45-6. PubMed ID: 3932389
[No Abstract] [Full Text] [Related]
39. The association of LDL receptor activity, LDL cholesterol level, and clinical course in homozygous familial hypercholesterolemia.
Sprecher DL; Hoeg JM; Schaefer EJ; Zech LA; Gregg RE; Lakatos E; Brewer HB
Metabolism; 1985 Mar; 34(3):294-9. PubMed ID: 3856094
[TBL] [Abstract][Full Text] [Related]
40. The metabolic basis of familial hypercholesterolemia.
Myant NB
Klin Wochenschr; 1983 Apr; 61(8):383-401. PubMed ID: 6306334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
